Fecal Microbial Transplantation for the Treatment of Persistent Multidrug-Resistant Klebsiella pneumoniae Infection in a Critically Ill Patient

Dysbiosis of the microbiome is a common finding in critically ill patients, who receive broad-spectrum antibiotics and various forms of organ support. Multidrug-resistant (MDR) organisms are a growing threat in all areas of medicine, but most markedly in the critically ill, where there is both loss...

Full description

Bibliographic Details
Main Authors: V. Ueckermann, E. Hoosien, N. De Villiers, J. Geldenhuys
Format: Article
Language:English
Published: Hindawi Limited 2020-01-01
Series:Case Reports in Infectious Diseases
Online Access:http://dx.doi.org/10.1155/2020/8462659
id doaj-09be61b234ac4887b1b7761a6fcb865b
record_format Article
spelling doaj-09be61b234ac4887b1b7761a6fcb865b2020-11-25T03:08:27ZengHindawi LimitedCase Reports in Infectious Diseases2090-66252090-66332020-01-01202010.1155/2020/84626598462659Fecal Microbial Transplantation for the Treatment of Persistent Multidrug-Resistant Klebsiella pneumoniae Infection in a Critically Ill PatientV. Ueckermann0E. Hoosien1N. De Villiers2J. Geldenhuys3Department Internal Medicine, University of Pretoria, Pretoria, South AfricaDepartment of Clinical Microbiology, Ampath National Reference Laboratory, Centurion, South AfricaGenetics Department, Ampath National Reference Laboratory, Centurion, South AfricaGenetics Department, Ampath National Reference Laboratory, Centurion, South AfricaDysbiosis of the microbiome is a common finding in critically ill patients, who receive broad-spectrum antibiotics and various forms of organ support. Multidrug-resistant (MDR) organisms are a growing threat in all areas of medicine, but most markedly in the critically ill, where there is both loss of host defences and widespread use of broad spectrum antibiotics. We present a case of a critically ill patient with persistent MDR Klebsiella pneumoniae infection, successfully treated with fecal microbiota transplantation (FMT), using stool of a rigorously-screened, healthy donor. FMT for Clostridium difficile colitis has been well described in the literature and is an established therapy for recurrent infections with Clostridium difficile. The use of FMT for other multidrug-resistant organisms is less frequently described, particularly in the context of critically ill patients. In our case, we have culture-documented clearance of the MDR Klebsiella pneumoniae form a patient of FMT.http://dx.doi.org/10.1155/2020/8462659
collection DOAJ
language English
format Article
sources DOAJ
author V. Ueckermann
E. Hoosien
N. De Villiers
J. Geldenhuys
spellingShingle V. Ueckermann
E. Hoosien
N. De Villiers
J. Geldenhuys
Fecal Microbial Transplantation for the Treatment of Persistent Multidrug-Resistant Klebsiella pneumoniae Infection in a Critically Ill Patient
Case Reports in Infectious Diseases
author_facet V. Ueckermann
E. Hoosien
N. De Villiers
J. Geldenhuys
author_sort V. Ueckermann
title Fecal Microbial Transplantation for the Treatment of Persistent Multidrug-Resistant Klebsiella pneumoniae Infection in a Critically Ill Patient
title_short Fecal Microbial Transplantation for the Treatment of Persistent Multidrug-Resistant Klebsiella pneumoniae Infection in a Critically Ill Patient
title_full Fecal Microbial Transplantation for the Treatment of Persistent Multidrug-Resistant Klebsiella pneumoniae Infection in a Critically Ill Patient
title_fullStr Fecal Microbial Transplantation for the Treatment of Persistent Multidrug-Resistant Klebsiella pneumoniae Infection in a Critically Ill Patient
title_full_unstemmed Fecal Microbial Transplantation for the Treatment of Persistent Multidrug-Resistant Klebsiella pneumoniae Infection in a Critically Ill Patient
title_sort fecal microbial transplantation for the treatment of persistent multidrug-resistant klebsiella pneumoniae infection in a critically ill patient
publisher Hindawi Limited
series Case Reports in Infectious Diseases
issn 2090-6625
2090-6633
publishDate 2020-01-01
description Dysbiosis of the microbiome is a common finding in critically ill patients, who receive broad-spectrum antibiotics and various forms of organ support. Multidrug-resistant (MDR) organisms are a growing threat in all areas of medicine, but most markedly in the critically ill, where there is both loss of host defences and widespread use of broad spectrum antibiotics. We present a case of a critically ill patient with persistent MDR Klebsiella pneumoniae infection, successfully treated with fecal microbiota transplantation (FMT), using stool of a rigorously-screened, healthy donor. FMT for Clostridium difficile colitis has been well described in the literature and is an established therapy for recurrent infections with Clostridium difficile. The use of FMT for other multidrug-resistant organisms is less frequently described, particularly in the context of critically ill patients. In our case, we have culture-documented clearance of the MDR Klebsiella pneumoniae form a patient of FMT.
url http://dx.doi.org/10.1155/2020/8462659
work_keys_str_mv AT vueckermann fecalmicrobialtransplantationforthetreatmentofpersistentmultidrugresistantklebsiellapneumoniaeinfectioninacriticallyillpatient
AT ehoosien fecalmicrobialtransplantationforthetreatmentofpersistentmultidrugresistantklebsiellapneumoniaeinfectioninacriticallyillpatient
AT ndevilliers fecalmicrobialtransplantationforthetreatmentofpersistentmultidrugresistantklebsiellapneumoniaeinfectioninacriticallyillpatient
AT jgeldenhuys fecalmicrobialtransplantationforthetreatmentofpersistentmultidrugresistantklebsiellapneumoniaeinfectioninacriticallyillpatient
_version_ 1715295662414757888